Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.1000 (-0.16%) ($16.0850 - $16.1000) on Mon. Aug. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.39% (three month average) | RSI | 55 | Latest Price | $16.1000(-0.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 2.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(45%) IBB(40%) ARKK(37%) IWO(37%) SKYY(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.195% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-7%) IGOV(-4%) TBT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.195% (StdDev 4.39%) | Hourly BBV | -1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $16.3 | 5 Day Moving Average | $16.51(-2.48%) | 10 Day Moving Average | $16.67(-3.42%) | 20 Day Moving Average | $16.3(-1.23%) | To recent high | -6.7% | To recent low | 51.1% | Market Cap | $2.841b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |